Chromium

DNA damage inducible transcript 3 ; Homo sapiens







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30547695 A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma. 2019 Apr 1
2 29477024 The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma. 2018 Apr 1
3 27077778 Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas. 2016 Oct 1
4 25641142 [Non-upper aerodigestive tract NK/T- cell lymphoma: an analysis of clinical features and survival from a single center in China]. 2015 Jan 1
5 26770342 Efficacy and safety of rituximab combined with chemotherapy in the treatment of diffuse large B-cell lymphoma: a meta-analysis. 2015 1
6 24356732 [Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma]. 2013 Jul 3
7 22752193 The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma. 2012 Nov 2
8 22781712 [Evaluation of the impact of R-CHOP chemotherapy on efficacy, safety and prognosis in newly diagnosed diffuse large B-cell lymphoma patients and its prognostic impact: a multicenter retrospective study with long term follow-up]. 2012 Apr 2
9 22175899 Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. 2011 Dec 1
10 19309523 R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature. 2009 Mar 24 1
11 19593797 Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA). 2009 Oct 1 1
12 18718094 [Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. 2008 Aug 2
13 15301718 [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. 2004 Aug 1
14 15585627 Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV). 2004 Dec 1 1
15 12270058 Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study. 2002 Jul 1
16 10580566 Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM. 1999 Nov 1
17 10920899 [Comparison of CHEP and CHOP chemotherapy in the management of non-Hodgkin's lymphoma]. 1997 May 1
18 17977418 [Treatment of non-Hodgkin's lymphomas of medium and high malignancy]. 1994 May-Jun 2
19 1699008 [The COP-BLAM therapy for malignant lymphoma]. 1990 Jul 1
20 2681883 [Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan]. 1989 Jul 2
21 6185212 Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study. 1983 Mar 15 2
22 84706 Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. 1979 Feb 2